2017 ACR/ARHP Annual Meeting

November 3-8, 2017. San Diego, CA.

View by Number View by Title View Sessions

View by Date

Abstract Number: 1979

Relationship between Religiosity /Spirituality and Physical and Mental Outcomes in Fibromyalgia Patients
Abstract Number: 1980

Impact of Whole-Body Cryotherapy on Gene Expression of Peripheral Blood Cells in Patients with Fibromyalgia and Association with Patient-Reported Outcomes
Abstract Number: 1981

The Etiology of Fibromyalgia May be Related to Increased Muscle Pressure
Abstract Number: 1982

Leptin, a Hypothalamic Signaling Hormone, Is Elevated in Fibromyalgia Patients
Abstract Number: 1983

The Types of Stress That Appear to Aggravate the Symptoms of Fibromyalgia
Abstract Number: 1984

The Cervical Spine in Fibromyalgia Patients: Loss of Lordotic Curve Is Characteristic of Fibromyalgia and Can Assist in the Diagnosis
Abstract Number: 1985

Cervical Spine Radiographs in Fibromyalgia Patients Show Reduced Cobb Angle and Suggest the Presence of Increased Muscle Pressure As a Cause of the Illness
Abstract Number: 1986

Using the BILAG to Assess the Activity of Lupus in Patients with Fibromyalgia
Abstract Number: 1987

Exercise in Fibromyalgia Patients
Abstract Number: 1988

Most Fibromyalgia Patients in a Rheumatology Office Practice Accept the Diagnosis of Fibromyalgia
Abstract Number: 1989

Improving Sleep in Fibromyalgia Patients Ameliorates Their Pain
Abstract Number: 1990

Effectiveness and Durability of a Brief Multidisciplinary Treatment Program for Patients with Fibromyalgia
Abstract Number: 1991

Fibromyalgia in Russian Refugees: Translation and Validation of the Revised Symptom Impact Questionnaire
Abstract Number: 1992

Changes in Clinical Disease Activity Are Associated with Changes in the Total MRI Inflammation Score in Rheumatoid Arthritis Patients Who Are Escalating Therapy in a Treat-to-Target (T2T) Regimen
Abstract Number: 1993

Are MRI-Detected Erosions Specific for RA? a Large Explorative Cross-Sectional Study

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].